PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Brinzolamide - Glaucoma
PAD Profile : Brinzolamide - Glaucoma Important
Brand Names Include :
Azopt
Important Information :
Prescribe generically
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Dorzolamide and timolol
- Brimonidine tartrate
- Dorzolamide
- Latanoprost and timolol
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 December 2021
Committee Recommendations
Date
Committee Name
Narrative
22 July 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.
Note; the branded product (Azopt) was considered as BLACK at the PCN in May 2017.
Associated BNF Codes
11. Eye
11.06.00. Treatment of glaucoma